p53 Mutations in Pancreatic Carcinoma and Evidence of Common Involvement of Homocopolymer Tracts in DNA Microdeletions

Cancer Research

Volumn 54, Issue 11, 1994, Pages 3025-3033

  Costa, Luis da ^b   Kern, Scott E ^a   Hruban, Ralph H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CANCER SURVIVAL; CHROMOSOME 17P; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; ONCOGENE RAS; PANCREAS ADENOCARCINOMA; POINT MUTATION; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 17; CODON; CONSERVED SEQUENCE; FEMALE; GENE DELETION; GENES, P53; GENES, RAS; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; POINT MUTATION; TUMOR CELLS, CULTURED;

EID: 0028308492     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Boring, C.C., Squires, T.S., and Tong, T. Cancer statistics, 1993. CA-Cancer J. Clin., 43: 7-26, 1993.
2. Hruban, R.H., van Mansfeld, A.O.M., Offerhaus, G.J.A., van Weering, D.H.J., Allison, D.C., Goodman, S.N., Kensler, T.W., Bose, K.K., Cameron, J.L., and Bos, J.L. K-ras oncogene activation in adenocarcinomas of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am. J. Pathol., 143: 545-554, 1993.
3. Fraumeni, J.F. Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res., 35: 3437-3446, 1975.
4. Liu, R.S., and Kessler, I.I. A multifactorial model for pancreatic cancer in man. J. Am. Med. Assoc., 245: 147-152, 1981.
5. Falk, R.T., Williams Pickle, L., Fontham, E.T., Correa, P., and Fraumeni, J.F. Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am. J. Epidemiol., 128: 324-336, 1988.
6. Lynch, H.T., Fitzsimmons, M.L., Smyrk, T.C., Lanspa, S.J., Watson, P., McClellan, J., and Lynch, J.F. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am. J. Gastroenterol., 85: 54-60, 1990.
7. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell, 53: 549-554, 1988.
8. Nigro, J.M., Baker, S.J., Preisinger, A.C., et al. p. 3 gene mutations occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
9. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
10. de Fromentel, C.C., and Soussi, J. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer, 4: 1-15, 1992.
11. Bressac B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p. 3 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
12. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., and Harris, C.C. Mutational hotspot in the p. 3 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
13. Brash, D.E., Rudolf, J.A., Simon, J.A., Lin, A., McKenna, G.J., Baden, H.P., Halperin, A.J., and Pontdn, J. A role for sunlight in skin cancer: UV-induced p. 3 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 88: 10124-10128, 1991
14. Bos, J.L., Fearon, E.R., Hamilton, S.R., et al Prevalence of ras gene mutations in human colorectal cancers. Nature (Lond.), 327: 293-297, 1987.
15. Cameron, J.L., Crist, D.W., Sitzman, J.V., Hruban, R.H., Boitnott, J.K., Seidler, A.J., and Coleman, J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am. J. Surg., 161: 120-125, 1991.
16. Vogelstein, B., Fearon, E.R., Kern, S.E., Hamnilton, S.R., Preisinger, A.C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989
17. Baker, S.J., Preisinger, A.C., Jessup, J.M., Paraskeva, C., Markowitz, S., Willson, J.K.V., Hamilton, S.R., and Vogelstein, B. p. 3 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7720, 1990.
18. Runnebaum, I.B., Nagarajan, M., Bowman, M., Soto, D., and Sukumar, S. Mutations in p. 3 as potential molecular markers for human breast cancer. Proc. Natl. Acad. Sci. USA, 88: 10657-10661, 1991.
19. Leach, F.S., Tokino, T., Meltzer, P., Burrell, M., Oliner, J.D., Smith, S., Hill, D.E., Sidransky, D., Kinzler, K.W., and Vogelstein, B. p. 3 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res., 53: 2231-2234, 1993.
20. Sidransky, D., Tokino, T., Hamilton, S.R., Kinzler, K.W., Levin, B., Frost, P., and Vogelstein, B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (Washington DC), 256: 102-105, 1992.
21. Hollstein, M.C., Metcalf, R.A., Welsh, J.A., Montesano, R., and Harris, C.C. Frequent mutation of the p. 3 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 87: 9958-9961, 1990.
22. Landegren, U., Kaiser, R., Sanders, J., and Hood, L. A ligase-mediated gene detection technique. Science (Washington DC), 241: 1077-1080, 1988.
23. Seymour, A.B., Hruban, R.H., Redston, M., Caldas, C., Powell, S.M., Kinzler, K.W., Yeo, C.J., and Kern, S.E. Allelotype of pancreatic adenocarcinoma. Cancer Res., 54: 2761-2764, 1994.
24. Ruggeri, B., Zhang, S.Y., Caamano, J., DiRado, M., Flynn, S.D., and Klein-Szanto, A.J.P. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p. 3 and Rb-1 tumor-supressor genes. Oncogene, 7: 1503-1511, 1992.
25. Barton, C.M., Staddon, S.L., Hughes, C.M., Hall, P.A., O'Sullivan, C., Kloppel, G., Theis, B., Russell, R.C.G., Neoptolemos, J., Williamson, R.C.N., Land, D.P., and Lemoine, N.R. Abnormalities of the p. 3 tumour suppressor gene in human pancreatic cancer. Br. J. Cancer, 64: 1076-1082, 1991.
26. Kalthoff, H., Schmiegel, W., Roeder, C., Kasche, D., Schmidt, A., Lauer, G., Thiele, H.G., Honold, G., Pantel, K., Riethmuller, G., Scherer, E., Maner, J., and Deppert, W. p. 3 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene, 8: 289-298, 1993.
27. Scarpa, A., Capelli, P., Mukai, K., Zamboni, G., Oda, T., Iacono, C., and Hirohashi, S. Pancreatic adenocarcinomas frequently show p. 3 gene mutations. Am. J. Pathol., 142: 1534-1543, 1993.
28. Casey, G., Yamanka, Y., Freiss, H., Kobrin, M.S., Lopez, M.E., Buchler, M., Beger, H.G., and Korc, M. p. 3 mutations are common in pancreatic carcinoma and are absent in chronic pancreatitis. Cancer Lett., 69: 151-160, 1993.
29. Streisinger, G., and (Emrich) Owen, J. Mechanisms of spontaneous and induced frameshift mutations in bacteriophage T4. Genetics, 109: 633-659, 1985.
30. Ripley, L.S. Frameshift mutation: determinants of specificity. Annu. Rev. Genet., 24: 189, 1990.
31. Kunkel, T.A. Misalignment-mediated DNA synthesis errors. Biochemistry, 29: 8003-8011, 1990.
32. Krawczak, M., and Cooper, D.C. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum. Genet., 86: 425-441, 1991.
33. Jego, N., Thomas, G., and Hamelin, R. Short direct repeats flanking deletions and duplicating insertions in p. 3 gene in human tumors. Oncogene, 8: 209-213, 1993.
34. Powell, S.M., Zilz, N., Beazer-Barclay, Y., Bryan, T.M., Hamilton, S.R., Thibodeau, S.N., Vogelstein, B., and Kinzler, K.W. APC mutations occur early during colorectal tumorigenesis. Nature (Lond.), 359: 235-237, 1992.
35. Nakatsuru, S., Yanagisawa, A., Ichii, S., Tahara, E., Kato, Y., Nakamura, Y., and Horii, A. Somatic mutations of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum. Mol. Genet., 1: 559-563, 1992.
36. Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T., and Nakamura, Y. Somatic mutations of APC gene in colorectal tumors: mutation cluster region of the APC gene. Hum. Mol. Genet., 1: 229-233, 1992.
37. Miyoshi, Y., Ando, H., Nagase, H., Nishisho, I., Horii, A., Miki, Y., Mori, T., Utsunomiya, J., Baba, S., Peterson, G., Hamilton, S.R., Kinzler, K.W., Vogelstein, B.V., and Nakamura, Y. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc. Natl. Acad. Sci. USA, 89: 4452-4456, 1992.
38. Olschwang, S., Laurent-Puig, P., Groden, J., White, R., and Thomas, G. Germ-line mutations in the first 14 exons of the adenomatous polyposis coli (APC) gene. Am. J. Genet., 52: 273-279, 1993.
39. Giannelli, F., Green, P.M., High, J.C.A., Sommer, S., Poon, M.C., Ludwig, M., Schwaab, R., Reitsma, P.H., Goossens, M., Yoshioka, A., and Brownlee, G.G. Haemophilia B: database of point mutations and short additions and deletions-fourth edition, 1993. Nucleic Acids Res., 21: 3075-3087, 1993.
40. Rouleau, G.A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., Pulst, S.M., Lenoir, G., Bijlsma, E., Fushold, R., Dumanski, J., de Jong, P., Parry, D., Eldrige, R., Aurias, A., Delattre, O., and Thomas, G. Alterations in a gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature (Lond.), 363: 515-521, 1993.
41. Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., Eldridge, R., Kley, N., Menon, A.G., Pulaski, K., Haase, V.H., Ambrose, C.M., Munroe, D., Bove, C., Haines, J.L., Martuza, R.L., MacDonald, M.E., Seizinger, B.R., Short, M.P., Buckler, A.J., and Gusella, J.F. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell, 72: 791-800, 1993.
42. DiGiuseppe, J.A., Hruban, R.H., Goodman, S.N., Allison, D.A., Cameron, J.L., and Offerhaus, J.G.A. Overexpression of the p. 3 tumor suppressor protein in pancreatic adenocarcinoma. Am. J. Clin. Pathol., 101: 684-688, 1994.
43. Rideout, W.M., III, Coetzee, G.A., Olumi, A.F., and Jones, P.A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p. 3 genes. Science (Washington DC), 249: 1288-1290.
44. Kraiss, S., Quaiser, A., Oren, M., and Montenarh, M. Oligomerization of oncoprotein p. 3. J. Virol., 62: 4737-4744, 1988.
45. Kern, S.E., Pietenpol, J.A., Thiagalingam, S., Seymour, A., Kinzler, K.W., and Vogelstein, B. Oncogenic forms of p. 3 inhibit p. 3-regulated gene expression. Science (Washington DC), 256: 827-830, 1992.
46. Roth, J.R. Frameshift mutations. Annu. Rev. Genet., 8: 319-346, 1974.
47. Hentschel, C.C. Homocopolymer sequences in the spacer of a sea urchin histone gene repeat are sensitive to SI nuclease. Nature (Lond.), 295: 714-716, 1982.
48. Streisinger, G., Okada, Y., Emrich, J., Tsugita, A., Terzaghi, E., and Inouye, M. Frameshift mutations and the genetic code. Cold Spring Harbor Symp. Quant. Biol., 31: 77-84, 1966.
49. Ke, S.H., and Wartell, R.M. Influence of nearest neighbor sequence on the stability of basepair mismatches in long DNA: determination by temperature-gradient gel electrophoresis. Nucleic Acids Res., 21: 5137-5143, 1993.
50. Parsons, R., Li, G.M., Longley, M.J., Fang, W., Papadopoulos, N., Jen, J., de la Chapelle, A., Kinzler, K.W., Vogelstein, B., and Modrich, P. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell, 75: 1227-1236, 1993.
51. Fishel, R., Lescoe, M.K., Rao, M.R.S., Copeland, N.G., Jenkins, N.A., Gerber, J., Kane, M., and Kolodner, R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75: 1027-1038, 1993.
52. Leach, F.S., Nicolaides, N.C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., PeltomSki, P., Sistonen, P., Aaltonene, L.A., Nystrom-Lahti, M., Guan, X.Y., Zhang, J., Meltzer, P.S., Yu, J.W., Kao, F.T., Chen, D.J., Cerosaletti, K.M., Founder, R.E.K., Todd, S., Lewis, T., Leach, R.J., Naylor, S.L., Weissenbach, J., Mecklin, J.P., Jarvinen, H., Peterson, G.M., Hamilton, S.R., Green, J., Jass, J., Watson, P., Lynch, H.T., Trent, J.M., de la Chapelle, A., Kinzler, K.W., and Vogelstein, B. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell, 75: 1215-1235, 1993.